The results of RE-LY and ATHENA have the potential to significantly change the treatment of atrial fibrillation. Dr Melissa Walton-Shirley sits down with Dr Nassir Marrouche to talk about what these treatment options mean for current atrial-fibrillation (AF) patients and what he thinks the world of AF treatment will look like in five years.